日本語はこちら

Call for Abstracts

[IMPORTANT] Disclosure of Conflict of Interest
The first author and co-authors are all required to disclose their Conflicts of Interest (COI) when submitting abstracts.
Co-authors who fail to disclose their COI status will be excluded from the author list in their abstracts.
Please refer to the "COI" page for more information.

Abstract Submission Period

Wednesday, June 4, 2025 - Wednesday, August 13, 2025 noon JST

Qualification

Both members and non-members of the JCS are qualified to submit the abstract.

Only JCS members can register for the Award Session.
If you would like to join the society, please apply from here.

Presentation format

We are calling for two types of presentation for the general session: Oral Presentation (Award Session) and Poster Presentations.

Categories

01 Angiogenesis 14 Gene therapy/Cell Therapy
02 Arteriosclerosis/Thromboembolism 15 Genetics and Epigenetics/Osmic Technologies
03 Aging 15 Heart Failure
04 Arrhythmia 17 Hypertension/Kidney/Interorgan Communication Network
05 Autonomic Nervous System 18 Inflammation
06 Autophagy and Cell Death 19 iPS
07 Cardiac hypertrophy and Function 20 Regeneration
08 Cardiac Metabolism 21 Mitochondria
09 Cardiomyopathy 22 Oxidative Stress
10 Cell Signaling 23 Pulmonary Hypertension
11 Development and Differentiation 24 Transcription and RNA biology
12 Diabetes/Metabolic Syndrome/Lipid Disorders 25 Vascular Biology
13 Drug Discovery/Translational Research 26 Others

Language

All abstracts must be submitted and presented in English.

Award Session

Presenter must be a member of the Japanese Circulation Society and under 40 years old, as of December 31, 2025.
Presenters for the Award Session will be selected from those who apply for the Award Session. Awardees will be selected during the session and receive supplemental prizes.
The Best Award JPY 200,000 / one person
Excellent Award JPY 100,000 / four people
JCS membership No. is required for the submission.
If you are unsure of your membership information, please contact to JCS office (email: jcs-bcvr@j-circ.or.jp)

  • If you are not selected for an oral presentation, it will be moved to a poster presentation instead.

Poster Award

The Poster Award will be selected from poster presentations.
The winner will receive a supplemental prize.

Disclosure of COI

In accordance with the common policy and regulations concerning conflict of interest (hereinafter "COI") in medical research and regulations concerning COI Policy in Medical Research, all presenters and co-presenters are required to self-disclose any COI status, including that of their spouse (partner), immediate family (first degree relatives), or those residing in the presenter's household. They must also describe any related commercial entities, foundations, organizations or other groups involved in medical research that aim to derive profit within the preceding three years.
Presenters must disclose their applicable COI status at the beginning of their slide presentation (or on a slide after the title slide and presenter names), or at the end of their poster.
Please download and fill in the "COI Self-Disclosure Form" below and sent it to the JCS office by email (jcs-bcvr@j-circ.or.jp) upon submitting your abstract.

COI Self-Discloseure Form

If there are co-authors, the COI of the co-authors must also be disclosed.
Please fill out the co-author sheets on the COI Self-Disclosure Form.

Notification of peer-review results

Notifications of acceptance/rejection and presentation styles, as well as the session date and time, will be sent to each registered email address around early November.

Abstract Submission

JCS member

instructionSubmission here

JCS non-member

instructionSubmission here

演題募集

演題登録期間

カテゴリー

01 Angiogenesis 14 Gene therapy/Cell Therapy
02 Arteriosclerosis/Thromboembolism 15 Genetics and Epigenetics/Osmic Technologies
03 Aging 15 Heart Failure
04 Arrhythmia 17 Hypertension/Kidney/Interorgan Communication Network
05 Autonomic Nervous System 18 Inflammation
06 Autophagy and Cell Death 19 iPS
07 Cardiac hypertrophy and Function 20 Regeneration
08 Cardiac Metabolism 21 Mitochondria
09 Cardiomyopathy 22 Oxidative Stress
10 Cell Signaling 23 Pulmonary Hypertension
11 Development and Differentiation 24 Transcription and RNA biology
12 Diabetes/Metabolic Syndrome/Lipid Disorders 25 Vascular Biology
13 Drug Discovery/Translational Research 26 Others

BCVR

第9回日本循環器学会基礎研究フォーラム 運営事務局
〒573-1116 枚方市船橋本町1-775 株式会社Atalacia内
Tel:072-807-3890 Fax:072-807-3898 bcvr2025@atalacia.com